Mary Kay Inc. Names Dr. Lucy Gildea Chief Brand and Scientific Officer
To empower future growth, iconic beauty and entrepreneurship company Mary Kay Inc. announced today the appointment of Dr. Lucy Gildea as Chief Brand and Scientific Officer.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250206167665/en/
Mary Kay Inc. Names Dr. Lucy Gildea Chief Brand and Scientific Officer. Gildea and her freshly designed cross-functional team will pioneer a new operating model to power up Mary Kay’s global brand and science aiming for growth and customer loyalty in over 40 markets. (Photo: Mary Kay Inc.)
Gildea and her freshly designed cross-functional team will pioneer a new operating model to power up Mary Kay’s global brand and science aiming for growth and customer loyalty in over 40 markets. In her expanded role, Gildea will shape a powerful brand identity, image, and strategy consistent across all platforms and geographies supported by an impactful product portfolio embracing the ever-evolving needs of consumers. She and her team will activate the brand through engagement strategies harnessing the power of next-gen entrepreneurs and resonant brand storytelling to win the hearts and minds of consumers.
"With her expertise in science and beauty innovation and customer-centric approach, Lucy will lead a strategic chapter of our transformation into the future. The new Global Brand and Science organization will contribute to our mutual business success by enabling our Independent Beauty Consultants to share a transformative brand experience with their customers and thrive as personal beauty advisors, thus reinforcing the unique value proposition of direct selling," said Ryan Rogers, Chief Executive Officer of Mary Kay and grandson of Mary Kay Ash.
Since joining Mary Kay in 2017, Gildea has focused on modernizing and enhancing the company's competitiveness through product innovation and by improving organizational efficiencies. Gildea spent 15 years at Procter & Gamble working primarily in beauty technology and beauty/skin product development. She also held a variety of senior roles including leading development teams for upstream technology and measurement sciences across healthcare, beauty and personal care industries. During her tenure at P&G, Gildea lived in Singapore, advancing her experience with international markets.
"Mary Kay was founded on a dream to enrich women’s lives with a product portfolio rooted in science. I am confident that integrating brand and science is the winning formula to meet global consumer needs and work toward our continued success. I look forward to maximizing synergies across our teams to captivate our Independent Beauty Consultants and invite a new generation of consumers to fall in love with our brand," said Dr. Lucy Gildea, Mary Kay’s Chief Brand and Scientific Officer.
Gildea earned a Ph.D. in Cell and Molecular Biology, Immunology, and Infectious Diseases at the University of Cincinnati College of Medicine and a Postdoctoral Research Fellowship in Immunology in a joint appointment with Cincinnati Children’s Hospital and the University of Cincinnati Department of Immunology. She also holds a Bachelor of Science in Biology from Georgetown College in Georgetown, Kentucky.
Gildea is a passionate STEM advocate for women and girls. She serves as a Board Member at Baylor Scott & White Dallas Foundation and a Board Advisor at Baylor Scott & White Charles A. Sammons Cancer Center.
This leadership appointment by Ryan Rogers honors Mary Kay Ash’s legacy of empowering women. At Mary Kay, women make up 63% of the R&D team, 54% of the executive team, and 63% of the global workforce1.
Did you know:
- In 2023 and again in 2024, Mary Kay was named the #1 Direct Selling brand of skin care & color cosmetics in the world by Euromonitor International2.
- Mary Kay holds more than 1,600 patents for products, technologies, and packaging designs in its global portfolio3.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women’s lives. That dream has blossomed into a global company with millions of Independent Beauty Consultants in more than 40 markets. For over 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse, and encouraging youth to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on X.
_______________________
1 Source: Women Representation and Leadership at Mary Kay (May 2024).
2 “Source Euromonitor International Limited; Beauty and Personal Care 2024 Edition, value sales at RSP, 2023 data”
3 As of 2023.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250206167665/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte To Present Initial Data for its TGFβR2×PD-1-directed Bispecific Antibody (INCA33890) and its Selective Inhibitor of G12D-mutated KRAS (INCB161734) at the European Society of Medical Oncology (ESMO) Congress 202524.7.2025 23:02:00 CEST | Press release
- Mini oral presentation to highlight initial Phase 1 data of INCA33890, a promising TGFβR2×PD-1-directed bispecific antibody, in patients with advanced or metastatic solid tumors - Oral presentation to feature initial data of INCB161734, a novel, selective and orally bioavailable inhibitor of G12D-mutated KRAS, in patients with advanced or metastatic solid tumors with KRASG12D mutations Incyte (Nasdaq:INCY) today announced that the Company will present key data from its oncology portfolio at the upcoming European Society of Medical Oncology (ESMO) Congress 2025, to be held October 17-21 in Berlin. “We're looking forward to presenting the latest findings across our oncology portfolio at this year’s congress, including initial data for our TGFβR2×PD-1-directed bispecific antibody, INCA33890, and our novel, selective and orally bioavailable inhibitor of G12D-mutated KRAS, INCB161734,” said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. “These data undersc
DNIB.com Reports Internet Has 371.7 Million Domain Name Registrations at the End of the Second Quarter of 202524.7.2025 23:01:00 CEST | Press release
VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that, according to the latest Domain Name Industry Brief Quarterly Report from DNIB.com, the second quarter of 2025 closed with 371.7 million domain name registrations across all top-level domains (TLDs), an increase of 3.3 million domain name registrations, or 0.9% compared to the first quarter of 2025. Domain name registrations also increased by 9.3 million, or 2.6%, year over year. The .com and .net TLDs had a combined total of 170.5 million domain name registrations in the domain name base at the end of the second quarter of 2025, an increase of 0.7 million domain name registrations, or 0.4% compared to the first quarter of 2025. The .com and .net TLDs had a combined decrease of 0.1 million domain name registrations, or 0.1%, year over year. As of June 30, 2025, the .com domain name base totaled 157.9 million domain name registrations and the .net
SES and the Luxembourg Government to Develop and Launch New Defence Satellite for GovSat24.7.2025 18:55:00 CEST | Press release
GovSat-2 is aimed at meeting growing demand for highly secure, flexible MILSATCOM services SES and the Luxembourg Government today announced their plan for development of a second satellite for GovSat (LuxGovSat S.A.), the public-private partnership and 50/50 joint venture between SES and the Luxembourg Government that provides secure, reliable and accessible satellite communication services for governments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250724379713/en/ GovSat-2. Copyright: Thales Alenia Space GovSat-2 will be positioned over the European satellite arc. It will join GovSat-1 in augmenting reliable connectivity services for government customers over the region. The satellite will be built by Thales Alenia Space on its Spacebus 4000B2 platform. Since launching in 2018, the joint venture’s first defence satellite, GovSat-1, operated by GovSat from a secure missions operations centre in Luxembourg, has supporte
Infobip Named a Leader in 2025 Gartner® Magic Quadrant™ for Communications Platform-as-a-Service for the Third Consecutive Year24.7.2025 18:21:00 CEST | Press release
Infobip positioned furthest in Completeness of Vision Global communications platformInfobiphas once again been named a Leader in the 2025 Gartner Magic Quadrant for Communications Platform-as-a-Service (CPaaS)1. This year the company is placed furthest in Completeness of Vision. Infobip views this third consecutive recognition as acknowledging its status as a global CPaaS powerhouse. Magic Quadrant2 reports are a culmination of rigorous, fact-based research in specific markets, providing a wide-angle view of the relative positions of the providers in markets where growth is high and provider differentiation is distinct. Providers are positioned into four quadrants: Leaders, Challengers, Visionaries and Niche Players. The research enables customers to get the most from market analysis in alignment with their unique business and technology needs. As a Leader, Infobip is recognized for both its Ability to Execute and its Completeness of Vision. Infobip powers conversations for some of the
Andersen Consulting fremmer digitale transformationsmuligheder med eksponentielle digitale løsninger24.7.2025 17:43:00 CEST | Pressemeddelelse
Andersen Consulting fortsætter med at opbygge sin digitale konsulentplatform gennem et samarbejde med Exponential Digital Solutions (10xDS), et firma der specialiserer sig i AI-drevet transformation og nye teknologier. 10xDS blev stiftet i 2016 af adminstrerende direktør Binu Koshy og leverer next generation-løsninger inden for automatisering, analyse, kunstig intelligens, cybersikkerhed og udvikling af digitale produkter. Virksomhedens tværfaglige tilgang kombinerer teknisk ekspertise med strategisk indsigt og støtter kunderne i deres implementering og skalering af next generation-løsninger. Med international erfaring inden for forskellige brancher arbejder 10xDS på at løse operationelle ineffektiviteter og skabe ny værdi gennem digital innovation. "Hos 10xDS har vi opbygget en organisation, der er baseret på innovation og troen på, at AI og nye teknologier kan føre til betydeligt bedre forretningsresultater," siger Binu. "Dette samarbejde understøtter vores mission om at skalere tran
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom